White matter hyperintensities are associated with subthreshold amyloid accumulation.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
09 2020
Historique:
received: 01 04 2020
revised: 30 04 2020
accepted: 11 05 2020
pubmed: 24 5 2020
medline: 20 2 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

The association between white matter hyperintensities (WMH) and amyloid accumulation over time in cognitively normal, amyloid-negative elderly people remains largely unexplored. In order to study whether baseline WMH were associated with longitudinal subthreshold amyloid accumulation, 159 cognitively normal participants from the Alzheimer's Disease Neuroimaging Initiative who were amyloid-negative at baseline were examined. All the participants underwent a T1 and a Fluid-Attenuated Inversion Recovery MRI scan at baseline. Amyloid PET imaging was performed at baseline and follow-up visits in 2-year intervals for up to 8 years. Partial volume correction was applied for quantifying cortical Standardised Uptake Value Ratios (SUVR). The associations between global and regional WMH burden and amyloid accumulation were assessed using linear mixed models adjusted by demographic characteristics and baseline SUVR. Partial volume correction increased the measured annual rate of change (+2.4%) compared to that obtained from non-corrected data (+0.5%). There were no significant correlations between baseline WMHs and baseline subthreshold cortical amyloid uptake. In a longitudinal analysis, increased baseline cortical SUVR and increased baseline burden of global (p ​= ​0.006), frontal (p ​= ​0.006), and parietal WMH (p ​= ​0.003) were associated with faster amyloid accumulation. WMH-related amyloid accumulation occurred in parietal, frontal, and, to a lesser extent, cingulate cortices. These results remained unchanged after a sensitivity analysis excluding participants with the highest cortical SUVRs. This is the first study to identify a specific spatial distribution of WMH which is associated with future amyloid accumulation in cognitively normal elderly subjects without PET-detectable amyloid pathology. These findings may have important implications in prevention trials for the early identification of amyloid accumulation.

Identifiants

pubmed: 32445880
pii: S1053-8119(20)30430-4
doi: 10.1016/j.neuroimage.2020.116944
pii:
doi:

Substances chimiques

Amyloid 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

116944

Subventions

Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest AM, DR, JS, JMA, JC, JP, AR, and PA report no relevant conflicts of interest.

Auteurs

Alexis Moscoso (A)

Nuclear Medicine Department, University Hospital CHUS-IDIS, Travesía da Choupana S/n, Santiago de Compostela, 15706, Spain; Molecular Imaging Group, Department of Radiology, Faculty of Medicine, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela, 15782, Spain.

David Rey-Bretal (D)

Molecular Imaging Group, Department of Radiology, Faculty of Medicine, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela, 15782, Spain.

Jesús Silva-Rodríguez (J)

Nuclear Medicine Department, University Hospital CHUS-IDIS, Travesía da Choupana S/n, Santiago de Compostela, 15706, Spain; Molecular Imaging Group, Department of Radiology, Faculty of Medicine, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela, 15782, Spain.

Jose M Aldrey (JM)

Neurology Department, University Hospital CHUS-IDIS, Travesía da Choupana S/n, Santiago de Compostela, 15706, Spain.

Julia Cortés (J)

Nuclear Medicine Department, University Hospital CHUS-IDIS, Travesía da Choupana S/n, Santiago de Compostela, 15706, Spain.

Juan Pías-Peleteiro (J)

Neurology Department, University Hospital CHUS-IDIS, Travesía da Choupana S/n, Santiago de Compostela, 15706, Spain.

Álvaro Ruibal (Á)

Nuclear Medicine Department, University Hospital CHUS-IDIS, Travesía da Choupana S/n, Santiago de Compostela, 15706, Spain; Molecular Imaging Group, Department of Radiology, Faculty of Medicine, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela, 15782, Spain.

Pablo Aguiar (P)

Nuclear Medicine Department, University Hospital CHUS-IDIS, Travesía da Choupana S/n, Santiago de Compostela, 15706, Spain; Molecular Imaging Group, Department of Radiology, Faculty of Medicine, University of Santiago de Compostela (USC), Campus Vida, Santiago de Compostela, 15782, Spain. Electronic address: pablo.aguiar.fernandez@sergas.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH